12.07.2015 Views

entire issue [pdf 12.7 mb] - Pitt Med - University of Pittsburgh

entire issue [pdf 12.7 mb] - Pitt Med - University of Pittsburgh

entire issue [pdf 12.7 mb] - Pitt Med - University of Pittsburgh

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

GO BUCS!Rocky Tuan holds a tiny terracotta–colored pirate ship. The realtreasure in the buccaneers’ boat isthe promise it holds in repairingknees, hips, and other joints ravagedby injury or disease.As director <strong>of</strong> the Center forCellular and Molecular Engineeringin <strong>Pitt</strong>’s Department <strong>of</strong> OrthopaedicSurgery, Tuan and postdoctoralassociate Hang Lin created theship with a 3-D printer, paid forby <strong>Pitt</strong>’s Clinical and TranslationalScience Institute, which they saywill one day create natural polymerimplants that contain the patient’sown living cells to repair joints.Tuan hopes to see the processbecome commonplace in his lifetime.Along with maintaining thepatient’s natural bone and t<strong>issue</strong>,the procedure would greatly reducethe amount <strong>of</strong> invasive surgery,recovery time, and cost involvedwith traditional joint replacement.And that’s plenty <strong>of</strong> reason to raisethe Jolly Roger.—Text and photo by John AltdorferAppointmentsJian-Min Yuan, an MD/PhD, will lead the Cancer Epidemiology,Prevention, and Control Program in the <strong>University</strong> <strong>of</strong> <strong>Pitt</strong>sburgh CancerInstitute. He will also serve as pr<strong>of</strong>essor <strong>of</strong> epidemiology in <strong>Pitt</strong>’s GraduateSchool <strong>of</strong> Public Health (GSPH) and associate director <strong>of</strong> cancer preventionand population science at the <strong>University</strong> <strong>of</strong> <strong>Pitt</strong>sburgh Cancer Institute.Yuan is interested in how environment, diet, behavior, and geneticsinfluence cancer. His investigations have included the potential rolesthat green tea, incense, and volatiles released by Chinese home cookingmight play in the disease. Yuan is a principal investigator on four NationalInstitutes <strong>of</strong> Health–funded projects; he comes to <strong>Pitt</strong>sburghfrom the <strong>University</strong> <strong>of</strong> Minnesota.One <strong>of</strong> the U.K.’s foremost ophthalmic surgeons is nowchief <strong>of</strong> the Division <strong>of</strong> Pediatric Ophthalmology at Children’sHospital <strong>of</strong> <strong>Pitt</strong>sburgh <strong>of</strong> UPMC, director <strong>of</strong> Pediatric ProgramDevelopment at UPMC Eye Center, and visiting pr<strong>of</strong>essor <strong>of</strong>ophthalmology at <strong>Pitt</strong>. Kanwal “Ken” Nischal came toYuan<strong>Pitt</strong>sburgh last fall from Great Ormond Street Hospital forChildren in London. In addition to his experience as a pediatriceye surgeon, Nischal has developed treatment algorithmsthat include innovative surgical techniques for children bornwith opaque corneas.Nathan Yates, a PhD, has been named associate pr<strong>of</strong>essor<strong>of</strong> cell biology in the School <strong>of</strong> <strong>Med</strong>icine and scientificdirector <strong>of</strong> <strong>Pitt</strong>’s Biomedical Mass Spectrometry Center. Ascodirector <strong>of</strong> the <strong>University</strong> <strong>of</strong> <strong>Pitt</strong>sburgh Cancer Institute’sCancer Biomarkers Facility, Yates will pursue research on the discoveryand measurement <strong>of</strong> protein biomarkers that may be usedto detect disease early and help doctors select the best treatments.Prior to joining <strong>Pitt</strong>, Yates was scientific director for theDepartment <strong>of</strong> Exploratory and Translational Science at Merck &Co., where he codeveloped differential mass spectrometry. At <strong>Pitt</strong>,Yates plans to collaborate with scientists from leading academicinstitutions to develop a groundbreaking cloud computing platformfor the storage and analysis <strong>of</strong> proteomics data.As <strong>of</strong> April, the McGowan Institute for Regenerative <strong>Med</strong>icinehas a new director and associate director. Pr<strong>of</strong>essor <strong>of</strong> SurgeryWilliam Wagner, a PhD who takes over as director, is one<strong>of</strong> the institute’s founders. Wagner’s research into cardiovascularengineering, focusing both on the monitoring <strong>of</strong> existingequipment and the development <strong>of</strong> new technologies, involvesgraduate and postdoctoral researchers from a broad range <strong>of</strong>specialties and has resulted in numerous patent filings and awards forinnovation. McGowan’s new associate director is Rocky Tuan (shownwith miniature ship above), a PhD and the Arthur J. Rooney Sr. Pr<strong>of</strong>essor<strong>of</strong> Sports <strong>Med</strong>icine in the Department <strong>of</strong> Orthopaedic Surgery. Beforecoming to <strong>Pitt</strong>sburgh in 2009, Tuan served as chief <strong>of</strong> the CartilageBiology and Orthopaedics Branch <strong>of</strong> the National Institute <strong>of</strong> Arthritis andMusculoskeletal and Skin Diseases. Tuan’s research has run the gamutfrom the development <strong>of</strong> the musculoskeletal system, to cell biochemistry,nanotechnology, and t<strong>issue</strong>-regeneration technology. —JHYatesWagnerNischal6 PITTMED

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!